Ira Sohn
Since 1996, the world-renowned Sohn Investment Conference has been the premier investment forum, bringing together the world's savviest investors to share fresh insights and strategies in support of pediatric cancer research and treatment.
Wall Street's best and brightest investors participate in this unique, 'must attend' event to share their expertise with an audience of more than 3,000 people, comprised of portfolio managers, asset allocators and private investors. Most speakers manage large proprietary investment portfolios that have outperformed the market for many years and do not share their insights in any public forum, but they volunteer their time to the Conference for the benefit of the Foundation. All contributions support the Foundation's mission to support pediatric research and care.
View Older Stories View More Recent Stories
-
Form 13F-NT B. Metzler seel. Sohn & For: Mar 31
-
Form 13F-HR B. Metzler seel. Sohn & For: Mar 31
-
The Pershing Square Sohn Cancer Research Alliance Awards $3.6 Million to Six Emerging Pioneers in Cancer Research
-
Analysis: U.S. investors looking for protection as inflation pressures bubble, stocks volatile
-
Form 4 Rubius Therapeutics, For: May 12 Filed by: Sohn Catherine A.
-
ATA Creativity Global Reports First Quarter 2021 Financial Results
-
Hedge funds bet on subscription-based businesses, pharmacy and copper
-
D1 Capital's Sundheim Discussing Netflix (NFLX) at Sohn Conf. - Bloomberg
-
Sohn Idea Contest winner Albert Wang pitches long Twilio (TWLO)
-
David Einhorn of Greenlight Capital Highlights Teck Resources (TECK) at Sohn
-
David Einhorn of Greenlight Capital highlights Freeport-McMoran (FCX) at Sohn as play on EVs
-
David Einhorn of Greenlight Capital highlights copper as a way to play EVs at Sohn
-
Lauren Taylor Wolfe of Impactive Capital discusses KBR, Inc. (KBR) at Sohn
-
Larry Robbins of Glenview discusses Butterfly Network (BFLY) at Sohn
-
Larry Robbins of Glenview discusses FAST Acquisition Corp. (FST) at Sohn
-
Larry Robbins of Glenview discusses Thoma Bravo Advantage (TBA) at Sohn
-
Larry Robbins of Glenview discusses Fortress Value Acquisition Corp. II (FAII) at Sohn
-
Larry Robbins of Glenview discusses Walgreens Boots Alliance (WBA) at Sohn
-
Larry Robbins of Glenview discusses McKesson (MCK) at Sohn
-
Larry Robbins of Glenview discusses Brookdale Senior Living (BKD) at Sohn
-
Larry Robbins of Glenview discusses Myriad Genetics (MYGN) at Sohn
-
Larry Robbins of Glenview discusses DXC Technology (DXC) at Sohn
-
BridgeBio Pharma Inc. (BBIO) Highlighted by Ellen Hukkelhoven at Sohn
-
Benchmark Capital's Gurley is Long Bitcoin, Short Doge: Sohn - Bloomberg
-
Apollo Medical Holdings, Inc. to Present at Upcoming Investor Conferences
-
ATA Creativity Global Schedules 2021 First Quarter Financial Results Release and Conference Call
-
U.S. hiring takes big step back as businesses scramble for workers, raw materials
-
Network Contagion Research Institute Names Adam Sohn Chief Executive Officer
-
Apollo Medical Holdings, Inc. Reports First Quarter 2021 Results
-
Blue Hat Announces First Quarter 2021 Financial Results, Highlighted by 343% Increase in Revenues to $9.9 Million and 62% Increase in Net Income to $1.2 Million
-
CPQSync™ by Cincom® is a Featured Partner at Microsoft Business Applications Summit on May 4
-
MEMX Breaks Multiple Monthly, Daily Records as It Climbs to 6th Largest Exchange in U.S.
-
Swiss-based Longevity-focused Startup Spiden Raises $18 Million to Expand Its Light+AI-based Real-time Blood Diagnostics Platform
-
Fiscal stimulus powers U.S. economic growth in first quarter
-
Data Is Great, But Humans Are Better: Hawkeye's Executives Lead with Empathy
-
CNPharm has succeeded in maintaining IC100 for 24 hours with one injection
-
Enzychem Lifesciences Announces Oral Presentation of TLR Signaling Inhibition with Mosedipimod (EC-18) at The International Liver Congress 2021 (EASL)
-
The 5th Annual Chart Summit Takes Place Saturday, April 17
-
ATA Creativity Global Announces Filing of Annual Report on Form 20-F for the Year Ended December 31, 2020
-
Marvin, Halio Inc. Announce Exclusive Agreement To Bring Halio® Smart Glass To Residential Market
-
CRN Names Ubisec Systems, Inc. To Its 2021 MSP 500 List
-
Enzychem Lifesciences Announces Last Patient Enrolled in Stage 2 of Phase 2 Study of EC-18 in Chemoradiation Induced Oral Mucositis
-
Extreme Tech Challenge Partners with TechCrunch, Extends Application Deadline, and Announces Four Specialized Awards for its 2021 Global Competition
-
Form 4 Griffin Capital Essentia For: Mar 25 Filed by: Sohn Louis K
-
ATA Creativity Global Reports 2020 Fourth Quarter and Year-end Financial Results
-
MEMX Completes Rollout of Groundbreaking Exchange Architecture
-
Samsung Develops Industry’s First HKMG-Based DDR5 Memory; Ideal for Bandwidth-Intensive Advanced Computing Applications
-
Samsung Develops Industry’s First HKMG-Based DDR5 Memory; Ideal for Bandwidth-Intensive Advanced Computing Applications
-
5th Stanford Drug Discovery Symposium (SDDS 2021) to be Held Virtually This Year on April 19-20, 2021
-
Maze Therapeutics Appoints Atul Dandekar as Chief Strategy Officer and Expands Board of Directors

